Lipocine Inc. Common Stock (NASDAQ: LPCN) last traded at $2.09, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from Lipocine Inc. Common Stock’s own filings and are restated only when a new one is published.
Lipocine Inc. Common Stock trades on NASDAQ under the ticker LPCN. Its market capitalisation is $17.23 million.
Valuation measures for Lipocine Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $17.23M |
|---|---|
| Enterprise value | $14.32M |
| Price / sales | 10.98 |
| Price / book | 0.79 |
| Beta | 1.38 |
Trailing-twelve-month figures tagged in Lipocine Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.57M |
|---|---|
| Net income (TTM) | -$11.85M |
| EPS (TTM) | -$1.79 |
| Operating margin | -800.82% |
| Return on equity | -54.45% |
| Cash | $4.98M |
Range and volume for LPCN over the past 52 weeks.
| 52-week high | $12.37 |
|---|---|
| 52-week low | $1.81 |
| Volume | 17.8K |
| Average volume | 66.1K |
| Previous close | $2.09 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.